• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床无功能性垂体腺瘤患者的促黄体生成素(LH)和促卵泡生成素(FSH)分泌以及对促性腺激素释放激素(GnRH)和促甲状腺激素释放激素(TRH)的反应。

LH and FSH secretion and responses to GnRH and TRH in patients with clinically functionless pituitary adenomas.

作者信息

White M C, Daniels M, Newland P, Thompson C J, Cook D, Dewar J, Perry R, Jewitt R, Mathias D, Murdoch A P

机构信息

Department of Medicine, University of Newcastle on Tyne, UK.

出版信息

Clin Endocrinol (Oxf). 1990 Jun;32(6):681-8. doi: 10.1111/j.1365-2265.1990.tb00914.x.

DOI:10.1111/j.1365-2265.1990.tb00914.x
PMID:2116944
Abstract

Serum concentrations of LH and FSH and their response to the separate administration of GnRH (100 micrograms i.v.) and TRH (200 micrograms i.v.) have been studied preoperatively in 12 patients with a clinically functionless pituitary adenoma, of whom nine (3F: 6M) were found to secrete gonadotrophins in vitro. In three patients with a gonadotrophin-secreting adenoma (GSA) the pulsatile release of LH and FSH was also assessed preoperatively. An elevated serum FSH was recorded in six of nine patients with a GSA, and was subnormal in one, whilst an elevated LH was recorded in only two and was subnormal in six. A doubling of LH occurred in only four of the nine patients after GnRH and in three of six after TRH. None of the three patients with a non-GSA was shown to have an aberrant response to GnRH or TRH. In patients with a GSA, pulsatile release of LH and FSH was usually asynchronous and neither hormone demonstrated any regular harmonic pattern. These data show that in patients with a GSA the serum FSH level is usually elevated but this is not invariable, and the LH may well be low. Pathological responses of LH are frequently found following the administration of either GnRH or TRH and these stimulation tests should be performed separately in patients presenting with a clinically 'non-functioning' pituitary tumour to assist in the preoperative diagnosis. The absence of normal LH and FSH pulsing also appears to be a feature of GS adenomas, and suggests that tumorous gonadotrophin secretion is not under physiological control by hypothalamic GnRH.

摘要

术前对12例临床无功能垂体腺瘤患者的血清促黄体生成素(LH)和促卵泡生成素(FSH)浓度及其对单独静脉注射促性腺激素释放激素(GnRH,100微克)和促甲状腺激素释放激素(TRH,200微克)的反应进行了研究,其中9例(3例女性:6例男性)在体外被发现分泌促性腺激素。对3例分泌促性腺激素腺瘤(GSA)患者术前也评估了LH和FSH的脉冲式释放。9例GSA患者中有6例血清FSH升高,1例低于正常水平,而LH升高的仅2例,6例低于正常水平。9例患者中仅4例在注射GnRH后LH加倍,6例中的3例在注射TRH后LH加倍。3例非GSA患者对GnRH或TRH均未表现出异常反应。在GSA患者中,LH和FSH的脉冲式释放通常不同步,两种激素均未表现出任何规律的谐波模式。这些数据表明,GSA患者血清FSH水平通常升高,但并非一成不变,LH很可能较低。在注射GnRH或TRH后经常发现LH的病理性反应,对于临床表现为“无功能”垂体肿瘤的患者,应分别进行这些刺激试验以协助术前诊断。LH和FSH正常脉冲式释放的缺失似乎也是GSA腺瘤的一个特征,这表明肿瘤性促性腺激素的分泌不受下丘脑GnRH的生理控制。

相似文献

1
LH and FSH secretion and responses to GnRH and TRH in patients with clinically functionless pituitary adenomas.临床无功能性垂体腺瘤患者的促黄体生成素(LH)和促卵泡生成素(FSH)分泌以及对促性腺激素释放激素(GnRH)和促甲状腺激素释放激素(TRH)的反应。
Clin Endocrinol (Oxf). 1990 Jun;32(6):681-8. doi: 10.1111/j.1365-2265.1990.tb00914.x.
2
Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro.促性腺激素释放激素激动剂([D-丝氨酸(叔丁基)6]促性腺激素释放激素(1-9)九肽乙酰胺)对人垂体促性腺激素细胞腺瘤体外促性腺激素分泌的长期影响。
J Endocrinol. 1988 Sep;118(3):491-6. doi: 10.1677/joe.0.1180491.
3
Combined beta FSH and beta LH response to TRH in patients with clinically non-functioning pituitary adenomas.临床无功能垂体腺瘤患者对促甲状腺激素释放激素(TRH)的β促卵泡生成素(FSH)和β促黄体生成素(LH)联合反应
Clin Endocrinol (Oxf). 1997 May;46(5):555-62. doi: 10.1046/j.1365-2265.1997.1720986.x.
4
Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.无功能垂体腺瘤患者促黄体生成素β亚基对促甲状腺激素释放激素的异常反应。
Clin Endocrinol (Oxf). 1994 Nov;41(5):661-6. doi: 10.1111/j.1365-2265.1994.tb01833.x.
5
The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors.促甲状腺激素释放激素对肢端肥大症和无功能垂体瘤患者促性腺激素及游离α亚基分泌的影响。
Thyroid. 1998 Oct;8(10):935-9. doi: 10.1089/thy.1998.8.935.
6
Gonadotrophin and alpha subunit secretion by human 'functionless' pituitary adenomas in cell culture: long term effects of luteinizing hormone releasing hormone and thyrotrophin releasing hormone.人“无功能”垂体腺瘤在细胞培养中的促性腺激素和α亚基分泌:促黄体生成素释放激素和促甲状腺激素释放激素的长期作用
Clin Endocrinol (Oxf). 1983 Sep;19(3):325-36. doi: 10.1111/j.1365-2265.1983.tb00006.x.
7
A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.促性腺激素、α亚基和嗜铬粒蛋白A在临床无功能、分泌α亚基和促性腺激素垂体腺瘤中的诊断价值及其对促甲状腺激素释放激素反应的比较。
J Clin Endocrinol Metab. 1993 Sep;77(3):784-9. doi: 10.1210/jcem.77.3.7690365.
8
Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.促性腺激素和α亚基对糖蛋白激素分泌型垂体瘤患者长期给予促性腺激素释放激素类似物的反应。
J Clin Endocrinol Metab. 1989 Jan;68(1):81-6. doi: 10.1210/jcem-68-1-81.
9
Secretion rates and short-term patterns of gonadotrophin-releasing hormone, FSH and LH in the normal stallion in the breeding season.繁殖季节正常种公马促性腺激素释放激素、促卵泡激素和促黄体生成素的分泌率及短期模式。
J Endocrinol. 1988 May;117(2):197-206. doi: 10.1677/joe.0.1170197.
10
Evidence that the TRH-like peptide pyroglutamyl-glutamyl-prolineamide in human serum may not be secreted by the pituitary gland.
J Endocrinol. 1997 Nov;155(2):393-9. doi: 10.1677/joe.0.1550393.

引用本文的文献

1
Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas.促性腺激素分泌型和无功能垂体腺瘤的药物治疗
Pituitary. 2002;5(2):89-98. doi: 10.1023/a:1022312530900.
2
Endocrine inactive and gonadotroph adenomas: diagnosis and management.内分泌无活性及促性腺激素腺瘤:诊断与管理
J Neurooncol. 2001 Sep;54(2):167-77. doi: 10.1023/a:1012965617685.
3
Gonadotrophin and free alpha-subunit secretion in patients with acromegaly and clinically non-functioning pituitary tumors: anterior pituitary function and the effect of thyrotrophin-releasing hormone.
肢端肥大症和临床无功能性垂体瘤患者的促性腺激素及游离α亚基分泌:垂体前叶功能及促甲状腺激素释放激素的影响
J Endocrinol Invest. 1996 Nov;19(10):663-9. doi: 10.1007/BF03349036.
4
Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.促甲状腺激素释放激素试验、SMS 201-995及溴隐亭在促性腺激素分泌型垂体腺瘤诊断和治疗中的应用价值。
J Endocrinol Invest. 1994 Feb;17(2):99-104. doi: 10.1007/BF03347693.
5
The silent corticotropinoma: is clinical diagnosis possible?无症状性促肾上腺皮质激素瘤:能否进行临床诊断?
J Endocrinol Invest. 1992 Jun;15(6):443-52. doi: 10.1007/BF03348769.